Making Virus Inactivation a Reality for Continuous Upscaled Processes

The Cadence™ Virus Inactivation (VI) system, a fully automated low pH virus inactivation system for both batch and continuous processing is one of the latest additions to Pall’s Continuous platform.  This webinar will discuss how traditional low pH virus inactivation has been translated into an automatic system, and also the additional challenges associated with making it a continuous process.  There will be a review of the two methods used for validating the design and an overview of the integration of capture chromatography and virus inactivation, which represents the first commercial scale combined unit operations in this space.

 

Moderator

tom watson

David Johnson

 

Senior Global Product Manager, Continuous Purification

Pall Biotech

Speakers

Mark Schofield

Mark Schofield, Ph.D.

 

Principal R&D Engineer
Pall Biotech

Making Virus Inactivation a Reality for Continuous Upscaled Processes

Download our eBook on Virus Safety

더 Biotech 웨비나
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
December 2020
Servicios de Validación de Filtración y Single Use Technology

Biotech | Pall Corporation 웨비나 시리즈

¡Todo sobre los ensayos de validaciones para cumplir con los máximos estándares regulatorios!

Hablaremos sobre puntos cruciales de los servicios de validación, incluyendo:

1. Necesidad de validación

2. Cómo se realizan los ensayos de validación

3. Análisis de riesgo: re uso de filtros y toma de decisión en ensayos a realizar

4. Servicio de Validación Pall: documentación requerida para iniciar una cotización

¡No pierdas esta segunda oportunidad!

시청